CAP-SAliPharm
Cold Atmospheric Plasma (CAP) sterilization of powdered products: optimization and validation at alimentary and pharmaceutical levels
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0CAP-SAliPharm project word cloud
Explore the words cloud of the CAP-SAliPharm project. It provides you a very rough idea of what is the project "CAP-SAliPharm" about.
Project "CAP-SAliPharm" data sheet
The following table provides information about the project.
| Coordinator |
HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE
Organization address contact info |
| Coordinator Country | Switzerland [CH] |
| Project website | https://www.hevs.ch/media/document/3/euresearch_plasma-tech-to-sterilise-food-and-pharma-powders.pdf |
| Total cost | 187˙419 € |
| EC max contribution | 187˙419 € (100%) |
| Programme |
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility) |
| Code Call | H2020-MSCA-IF-2016 |
| Funding Scheme | MSCA-IF-EF-ST |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-01-01 to 2019-12-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | HAUTE ECOLE SPECIALISEE DE SUISSE OCCIDENTALE | CH (DELEMONT) | coordinator | 187˙419.00 |
Map
Project objective
Insight market requirements are leading the R&D at food technology area to provide ready-to-eat products, microbiologically safe, with organoleptic and nutritional added value, and as longest as possible shelf-life guided by international trade search of competitiveness. Powders are worldwide distributed commodities. Valuable properties associated to them are: stability; easy storage and transportation; nutritional compounds integrated in formulas; price; and limited microbial proliferation. In spite of these characteristics, nowadays the sterilization of powders is not completely solved. Spore-forming bacteria are widely capable to survive in powders during long periods of time, initiating after the rehydration process, a rapid germination and proliferative activity with fatal consequences mainly in infant and elderly. The present project aims to analyse the Cold Atmospheric Plasma (CAP) technology application integrating the study of process parameters and reference powders characteristics to optimize the sterilization process of alimentary and pharmaceutical products. Moreover, the optimized conditions will be validated in real matrices, infant powder (milk formula and cereals) and multivitamin and protein complexes. Finally, the optimized conditions at pre-industrial level will be delivered in technical sheets regarding the technological, microbiological and risk-assessment relevant outputs of the project, contributing to provide the methodological basis for the industrial establishment of more sustainable production of a new generation of powdered products. Such system for powders sterilization has not been described previously and is one of the most ambitious points of research in the present MSCA framework. The present project aims to contribute to the cutting-edge of this technology application at International level, making a significant impact on the position of the European Union in the know-how regarding CAP application.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CAP-SALIPHARM" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CAP-SALIPHARM" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.1.3.2.)
IRF4 Degradation (2019)
Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells
Read More